Mostrar el registro sencillo del ítem
| dc.contributor.author | Valera-Novella, Elisa | |
| dc.contributor.author | Bernabeu-Mora, Roberto | |
| dc.contributor.author | Montilla-Herrador, Joaquina | |
| dc.contributor.author | Escolar-Reina, Pilar | |
| dc.contributor.author | García-Vidal, José-Antonio | |
| dc.contributor.author | Medina-Mirapeix, Francesc | |
| dc.date.accessioned | 2025-11-20T07:25:18Z | |
| dc.date.available | 2025-11-20T07:25:18Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | Valera-Novella E, Bernabeu-Mora R, Montilla-Herrador J, Escolar-Reina P, García-Vidal JA, Medina-Mirapeix F. Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations. Therapeutic Advances in Chronic Disease. enero de 2023;14:20406223231155115. | |
| dc.identifier.issn | 2040-6223 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/21577 | |
| dc.description.abstract | BACKGROUND: In chronic obstructive pulmonary disease (COPD), multiple recurrent severe exacerbations that require hospitalization can occur. These events are strongly associated with death and other clinical complications. OBJECTIVES: We aimed to develop a prognostic model that could identify patients with COPD that are at risk of multiple recurrent severe exacerbations within 3 years. DESIGN: Prospective cohort. METHODS: The derivation cohort comprised patients with stable, moderate-to-severe COPD. Multivariable logistic regression analyses were performed to develop the final model. Based on regression coefficients, a simplified index (ESEx) was established. Both, model and index, were assessed for predictive performance by measuring discrimination and calibration. RESULTS: Over 3 years, 16.4% of patients with COPD experienced at least three severe recurrent exacerbations. The prognostic model showed good discrimination of high-risk patients, based on three characteristics: the number of severe exacerbations in the previous year, performance in the five-repetition sit-to-stand test, and in the 6-minute-walk test. The ESEx index provided good level of discrimination [areas under the receiver operating characteristic curve (AUCs): 0.913]. CONCLUSIONS: The ESEx index showed good internal validation for the identification of patients at risk of three recurrent severe COPD exacerbations within 3 years. These tools could be used to identify patients who require early interventions and motivate patients to improve physical performance to prevent recurrent exacerbations. | |
| dc.language.iso | eng | |
| dc.publisher | SAGE PUBLICATIONS LTD | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | |
| dc.rights.uri | Atribución-NoComercial-SinDerivadas 3.0 España | * |
| dc.title | Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 38405221 | |
| dc.relation.publisherversion | https://journals.sagepub.com/doi/10.1177/20406223231155115 | |
| dc.identifier.doi | 10.1177/20406223231155115 | |
| dc.journal.title | Therapeutic Advances in Chronic Disease | |
| dc.identifier.essn | 2040-6231 |